The National Cancer Institute is now offering "Risk Disk"

The National Cancer Institute is now offering "Risk Disk"... a computer program to help estimate a woman's risk of breast cancer.

This is important now that Nolvadex (tamoxifen) is approved to reduce the incidence of breast cancer in women at high risk.

The Risk Disk asks about the woman's age...age of menarche...age at first live history of breast cancer...and personal medical history.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote